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Introduction {#s1}
============

Coal Workers\'Pneumoconiosis (CWP) is a serious occupational disease derived from inhalation and deposition of occupational coal mine dust and/or silica particulates in the lungs. The exposure may lead to the aberrant proliferation of activated fibroblasts, pathological remodeling, and excessive deposition of extracellular matrix (ECM) in lung tissues [@pone.0105226-Nawrot1], [@pone.0105226-King1]. Currently, there is no effective treatment of CWP. In China, 87.72% of the reported occupational cases were attributed to pneumoconiosis in 2013, of which CWP (60.28%) and silicosis (34.96%) accounted for the majority [@pone.0105226-Bin1]. The incidence and progression of CWP are related to both dust exposure levels and silica content in the dust [@pone.0105226-Wang1]. However, only a portion of individuals exposed to coal dust or silica develop CWP in their lifetime, suggesting that genetic susceptibility factors also play a role in the development of CWP [@pone.0105226-Chen1].

SPARC (secreted protein, acidic and rich in cysteine), also known as osteonectin or BM-40, is a 43 kilo-Dalton matricellular glycoprotein which is secreted into the extracellular space along with other extracellular matrix components, including collagens, but does not serve a structural function in the ECM [@pone.0105226-TrombettaEsilva1]. SPARC participates to not only regulate cell-cell and cell-matrix interactions, but also modify ECM deposition, influence angiogenesis, and alter the activity of a number of cytokines and growth factors [@pone.0105226-Bradshaw1], such as stimulating the transforming growth factor beta (TGF-β) signaling system [@pone.0105226-Wang2]. In addition, SPARC-null mice display a lesser amount of pulmonary fibrosis compared with wild type mice in animal models of bleomycin-induced pulmonary fibrosis [@pone.0105226-Strandjord1]. These points indicate that SPARC may play an important role in tissue fibrosis.

Single nucleotide polymorphisms (SNPs) are the most frequent sequence variations in the human genome. The SPARC gene is located on human chromosome 5q31-32 [@pone.0105226-Liu1], and there are at least 800 SNPs of SPARC reported in the SNP database (<http://www.ncbi.nlm.nih.gov/snp>). Most of these are located in introns. SNPs located in exon regions may alter protein function, whereas SNPs in the gene promoter modify gene expression at transcription levels. SNPs in the 3′-untranslated region (3′-UTR) may be regulated by microRNA at translational levels.

There are a total of ten SNPs in the functional regions of the SPARC: one (rs2304052) in the exon, one (rs4958281) in 5′-UTR, and eight in 3′-URT with a minor allele frequency (MAF) greater than 0.05 in the Chinese population. Therefore, we selected the two SNPs located in the exon and 5′-UTR. Among the eight SNPs in 3′-UTR, three SNPs (rs1059279, rs1059829 and rs1053411) were selected based on a linkage coefficient of r^2^\>0.80. To date, there is no literature on genetic variants in SPARC and their roles in susceptibility to CWP. Therefore, the current study aimed to investigate the associations of five functional SNPs in SPARC and the susceptibility to CWP in the Chinese population, as well as their impact on the progression of the disease.

Materials and Methods {#s2}
=====================

Study subjects {#s2a}
--------------

From January 2006 to December 2010, 694 healthy males and 697 males with definite CWP were recruited from the coal mines of Xuzhou Mining Business Group Co., Ltd., as described previously [@pone.0105226-Wang3]. All subjects in our study were ethnic Han Chinese without a direct family/genetic relationship. All studied individuals were selected from the same mines. Subjects were excluded if they had clinical evidence of autoimmune diseases, had received immunosuppressive or immunostimulatory therapy, or were subjected to radiotherapy. High kilovolt chest X-rays and physical examinations were performed to confirm diagnoses based on the China National Diagnostic Criteria for Pneumoconiosis (GBZ 70-2002). These criteria are identical to the 1980 International Labour Organization (ILO) in the judgment of opacity profusion [@pone.0105226-Wang1], [@pone.0105226-Zhang1]. Two independent physicians (Z. Song and X. Jia) assessed the chest X-rays. Pneumoconiosis cases were classified into stage I, stage II or stage III according to the size, profusion, and opacity distribution range. Controls were recruited from healthy subjects who were seeking outpatient physical examinations at the hospital department, and were frequency matched on age (±5 years), dust exposure period, and occupation. Using a double-blind investigation method, live interviewers conducted participant questionnaires. The epidemiological questionnaire focused on age, respiratory symptoms, occupational histories, and smoking habits. Five milliliter blood samples were obtained from all subjects and used for routine laboratory tests. A written informed consent was obtained from each subject before participating in the study. The protocol and consent form were approved by the Institutional Review Board of Nanjing Medical University (FWA00001501).

SNPs selection {#s2b}
--------------

To select the most likely functional SNPs influencing the *SPARC* gene, we selected the SNPs located in the exon, 3′-UTR, and 5′-UTR, as determined in the HapMap Genome Browser release (Phase 1 & 2 release - full dataset). We included the following criteria for SNPs: (i) the SNPs should be located in the exon, 3′UTR and 5′UTR, (ii) the minor allele frequency (MAF) should be \>5% in the Chinese Han Beijing population (CHB), and (iii) in the case of multiple SNPs in the same haplotype block (linkage coefficient r^2^\>0.8 in CHB of 1000 Genome database), only the most representative SNP was selected. Ultimately, three SNPs (rs1059279, rs1053411, and rs1059829) located in 3′UTR, one SNP rs2304052 in the exon, and one SNP rs958281 located in 5′UTR were included in the study. The LD results of these five chosen SNPs demostrated that rs1059829 had a medium linkage disequilibrium with rs1053411 (RSquared = 0.786), however, the rs1059279 was not included in 1000 Genome database.

Genotyping {#s2c}
----------

Genomic DNA was extracted from leukocyte pellet by proteinase K digestion and followed by phenol-chloroform extraction and ethanol precipitation. Genotyping was performed using the TaqMan method with the ABI 7900 real-time PCR system (Applied Biosystems, Foster City, CA, USA). SDS allelic discrimination software (version 2.4, provided by ABI) was used for analysis of genotyping results.

The sequences of the primers and probes for each SNP are available on request. Further detailed information about the sequence of each primer and probe is listed in [Table S1](#pone.0105226.s001){ref-type="supplementary-material"}. Amplification was performed in a total volume of 5 µl, containing 50 ng of genomic DNA, 2.5 µl of Mix, 0.25 µl of each primer, 0.125 µl of each probe and 1.25 µl Nuclease-Free Water, under the following conditions: 50°C for 2 minutes and 95°C for 10 minutes followed by 45 cycles of 95°C for 15 seconds and 60°C for 1 minute. Negative controls were included in each plate to ensure accuracy of genotyping. For quality control, genotyping was done in a blinded fashion without knowledge of the workers\' personal details or case/control status of subjects. Furthermore, a random 10% of cases and controls were genotyped twice by different individuals, with a reproducibility of 100%. All relevant data are within [Data S1](#pone.0105226.s002){ref-type="supplementary-material"}.

Statistical analyses {#s2d}
--------------------

Deviations of the characteristics for CWP patients and control subjects were examined by the Student-*t* test (for continuous variables) or the *χ^2^* test (for categorical variables). Differences in allele and genotype frequencies of the two groups were assessed using the Pearson χ2 test or Fisher\'s exact test. Unconditional multivariate logistic regression analyses adjusting for age, exposure years, pack-years smoked, and occupation, were used to estimate ORs and the 95% confidence interval (CI) for assessing the strength of association between the polymorphisms in *SPARC* and risk of coal workers\' pneumoconiosis under various genetic models. These were defined as Aa versus AA and aa versus AA for co-dominant, aa+Aa versus AA for dominant, aa versus AA+Aa for recessive, and a versus A for additive model (A: major allele, a: minor allele). Hardy-Weinberg equilibrium (HWE) was tested using a goodness-of-fit χ^2^-test. For the stratified analysis, the dust-exposure cut-off used was based on median dust-exposure years of the recruited patients and controls. Genotypes were coded as wild types (major-allele homozygote) and variants (minor-allele homozygote and heterozygote). *P*-values of less than 0.05 were considered statistically significant. All statistical tests were two-sided and were analyzed with R software (version 3.0).

Results {#s3}
=======

Demographic and clinical information is summarized in [Table 1](#pone-0105226-t001){ref-type="table"}. No significant differences were observed for age (*P* = 0.103), exposure years (*P* = 0.105), or occupation (*P* = 0.534) between CWP patients and controls. The distribution of smoking status between cases and controls was parallel (*P* = 0.250). As expected, smoking amount (pack- years) in CWP cases was significantly more than that of controls (*P*\<0.001). Pneumoconiosis stages from I to III were identified as 59.5%, 31.4%, and 9.0%, respectively.

10.1371/journal.pone.0105226.t001

###### Demographic and selected variables among the CWP cases and control subjects.

![](pone.0105226.t001){#pone-0105226-t001-1}

  Variables                   CWP(n = 697)   Controls(n = 694)    *P*          
  -------------------------- -------------- ------------------- ------- ------ ---------
  Age, years (mean±SD)         68.0±11.1         67.1±8.4        0.103         
  Exposure years (mean±SD)      26.6±9.0         27.3±7.8        0.105         
  Smoking status                                                               
  Never                           340              48.8           360    51.9    0.250
  Ever                            357              51.2           334    48.1  
   Former                         163              23.4           91     13.1  
   Current                        194              27.8           243    35.0  
  Pack-years smoked                                                             \<0.001
  0                               340              49.2           360    52.6  
  0--20                           223              32.0           132    19.0  
  \>20                            134              19.2           202    29.1  
  Occupation                                                                     0.534
  Tunnel and coal mining          663              95.1           652    94.0  
  Transport                        16               2.3           17     2.5   
  Others                           18               2.6           25     3.6   
  Stage                                                                        
  I                               415              59.5                        
  II                              219              31.4                        
  III                              63               9.0                        

Details for the SNPs detected in our study are summarized in [Table 2](#pone-0105226-t002){ref-type="table"}. All genotyped distributions of control subjects were consistent with those expected from the HWE. The MAFs of these five polymorphisms were consistent with those reported in the HapMap database.

10.1371/journal.pone.0105226.t002

###### Primary information of genotyped SNPs.

![](pone.0105226.t002){#pone-0105226-t002-2}

  Cluster ID    Region   dbSNP allele   MAF    HWE^b^         
  ------------ -------- -------------- ------ -------- ------ -------
  rs1059279     3′UTR        A\>C       0.33    0.33    0.30   0.410
  rs4958281     5′UTR        C\>T       0.08    0.04    0.05   0.693
  rs2304052      Exon        T\>C       0.07    0.07    0.08   0.297
  rs1059829     3′UTR        C\>T       0.48    0.39    0.35     1
  rs1053411     3′UTR        C\>G       0.33    0.34    0.30   0.929

dbSNP^a^ based on Asian in dbSNP;

HWE^b^ (Hardy--Weinberg equilibrium) *P* value of the control group.

Furthermore, we performed a multivariate logistic regression analysis to assess the effect of each SNP on CWP risk (adjusting for age, exposure years, pack-years smoked, and occupation). Parameters for the association of SNPs with CWP are shown in [Table 3](#pone-0105226-t003){ref-type="table"}. There are three SNPs (rs1059279, rs1059829, rs1053411) significantly associated with the risk of CWP. Analysis under different genetic models revealed that the risk allele increased the susceptibility to CWP under co-dominant (OR = 1.63, 95%CI = 1.12--2.37, *P* = 0.011 for CC versus AA for rs1059279; OR = 1.56, 95%CI = 1.13--2.17, *P* = 0.007 for TT versus CC for rs1059829; OR = 1.49, 95%CI = 1.04--2.14, *P* = 0.029 for GG versus CC for rs1053411), recessive (OR = 1.53, 95%CI = 1.07--2.19, *P* = 0.021 for rs1059279; OR = 1.52, 95%CI = 1.12--2.06, *P* = 0.007 for rs1059829; OR = 1.43, 95%CI = 1.01--2.01, *P* = 0.041 for rs1053411), and additive (OR = 1.2, 95%CI = 1.02--1.41, *P* = 0.027 for rs1059279; OR = 1.20, 95%CI = 1.03--1.39, *P* = 0.021 for rs1059829; OR = 1.17, 95%CI = 1.00--1.38, *P* = 0.044 for rs1053411) models. These associations remained significant after adjusting for age, exposure years, pack-years smoked, and occupation, except for the correlation between rs1059829 and CWP risk under an additive model. As for rs2304052 and rs4958281, none of the genetic models showed any effect of the minor allele on the development of CWP.

10.1371/journal.pone.0105226.t003

###### Distributions of genotypes and their associations with risk of CWP.

![](pone.0105226.t003){#pone-0105226-t003-3}

  Variables    CWP cases   Controls   OR (95%CI)[a](#nt103){ref-type="table-fn"}   *P* [a](#nt103){ref-type="table-fn"}   OR (95%CI)[b](#nt104){ref-type="table-fn"}   *P* [b](#nt104){ref-type="table-fn"}                                      
  ----------- ----------- ---------- -------------------------------------------- -------------------------------------- -------------------------------------------- -------------------------------------- --------- ------------ ------------ ---------
  rs1059279     n = 692    n = 689                                                                                                                                                                                                               
  AA              309        44.8                        337                                       48.9                                      1.00                                      1.00                                                      
  AC              301        43.5                        297                                       43.1                                      1.11                                   0.88--1.38                 0.378       1.11      0.89--1.39    0.340
  CC              82         11.7                         55                                       8.0                                       1.63                                   1.12--2.37                 0.011       1.63      1.12--2.38    0.011
  Dominant                                                                                                                                   1.18                                   0.95--1.46                 0.126       1.25      0.91--1.71    0.163
  Recessive                                                                                                                                  1.53                                   1.07--2.19                 0.021       2.41      1.34--4.33    0.003
  Additive                                                                                                                                   1.2                                    1.02--1.41                 0.027       1.35      1.06--1.71    0.015
  rs4958281     n = 692    n = 689                                                                                                                                                                                                               
  CC              633        91.4                        621                                       90.1                                      1.00                                      1.00                                                      
  TC              59         8.5                          66                                       9.6                                       0.88                                   0.61--1.27                 0.485       0.88      0.60--1.27    0.481
  TT               0          0                           2                                        0.3                                     \-\-\--                                   \-\-\--                  \-\-\--    \-\-\--      \-\-\--     \-\-\--
  Dominant                                                                                                                                   0.85                                   0.59--1.23                 0.388       0.63      0.37--1.06    0.083
  Recessive                                                                                                                                  0.00                                    0.00-inf                  0.999       0.00        0-inf       0.999
  Additive                                                                                                                                   0.83                                   0.58--1.19                 0.306      0.621      0.37--1.04    0.070
  rs2304052     n = 692    n = 689                                                                                                                                                                                                               
  TT              593        85.7                        587                                       85.2                                      1.00                                      1.00                                                      
  CT              95         13.7                         96                                       13.9                                      1.00                                   0.72--1.33                 0.895       0.98      0.72--1.34    0.909
  CC               4         0.6                          6                                        0.9                                       0.66                                   0.19--2.35                 0.521       0.60      0.17--2.16    0.438
  Dominant                                                                                                                                   0.96                                   0.71--1.30                 0.793       0.86      0.55--1.34    0.515
  Recessive                                                                                                                                  0.66                                   0.19--2.36                 0.524       0.48      0.08--2.96    0.426
  Additive                                                                                                                                   0.95                                   0.72--1.25                 0.699       0.85      0.56--1.28    0.436
  rs1059829     n = 690    n = 687                                                                                                                                                                                                               
  CC              270        39.1                        293                                       42.6                                      1.00                                      1.00                                                      
  TC              302        43.8                        312                                       45.4                                      1.05                                   0.84--1.32                 0.674       1.05      0.84--1.13    0.650
  TT              118        17.1                         82                                       11.9                                      1.56                                   1.13--2.17                 0.007       1.56      1.13--2.17    0.008
  Dominant                                                                                                                                   1.16                                   0.93--1.43                 0.184       1.18      0.86--1.62    0.319
  Recessive                                                                                                                                  1.52                                   1.12--2.06                 0.007       1.72      1.09--2.72    0.021
  Additive                                                                                                                                   1.20                                   1.03--1.39                 0.021       1.24      0.99--1.55    0.059
  rs1053411     n = 692    n = 689                                                                                                                                                                                                               
  CC              308        44.5                        333                                       48.3                                      1.00                                      1.00                                                      
  GC              297        42.9                        293                                       42.5                                      1.10                                   0.88--1.37                 0.422       1.09      0.88--1.37    0.423
  GG              87         12.6                         63                                       9.1                                       1.49                                   1.04--2.14                 0.029       1.48      1.03--2.13    0.032
  Dominant                                                                                         1.17                                   0.94--1.44                                  0.155                    1.25     0.91--1.71     0.165     
  Recessive                                                                                        1.43                                   1.01--2.01                                  0.041                    1.99     1.17--3.39     0.011     
  Additive                                                                                         1.17                                   1.00--1.38                                  0.044                    1.31     1.03--1.65     0.025     

Two-sided x^2^ test.

Adjusted for age, exposure years, pack-years smoked, and occupation.

The associations between each of these three SNPs (rs1059279, rs1059829, rs1053411) and CWP risk were further stratified by exposure years and pack-years smoked. As shown in [Table 4](#pone-0105226-t004){ref-type="table"}, the association between rs1059279 and CWP risk remained significant among subjects who had greater than 27 years of exposure (OR = 1.27, 95%CI = 1.03--1.56, *P* = 0.023) and individuals with 0--20 pack-years smoked (OR = 1.73, 95%CI = 1.21--2.45, *P* = 0.002) under an additive model. In addition, the variants rs1059829 and rs1053411 both also significantly increased CWP risk of individuals with 0--20 pack-years smoked (OR = 1.48, 95%CI = 1.07--2.05, *P* = 0.019 for rs1059829; OR = 1.58, 95%CI = 1.13--2.22, *P* = 0.008 for rs1053411) under an additive model. The function prediction results of these three SNPs are listed in [Table 5](#pone-0105226-t005){ref-type="table"}.

10.1371/journal.pone.0105226.t004

###### Stratification analyses between the genotypes of three SNPs and CWP risk.

![](pone.0105226.t004){#pone-0105226-t004-4}

  Variables             rs1059279    rs1059829       rs1053411                                                                                                                
  -------------------- ------------ ------------ ------------------ ------- ------------ ------------ ------------------ ------- ------------ ------------ ------------------ -------
  Exposure years                                                                                                                                                              
  \<27                  28/110/132   16/120/129   1.11(0.85--1.45)   0.447   43/114/112   29/119/117   1.17(0.91--1.50)   0.210   31/109/130   21/115/129   1.10(0.85--1.43)   0.470
  ≥27                   54/191/177   39/177/208   1.27(1.03--1.56)   0.023   75/188/158   53/193/176   1.21(1.00--1.47)   0.052   56/188/178   42/178/204   1.21(1.00--1.49)   0.059
  Pack--years smoked                                                                                                                                                          
  0                     40/135/165   31/156/171   1.05(0.84--1.32)   0.664   62/136/141   46/163/148   1.11(0.90--1.37)   0.331   41/140/159   36/152/170   1.05(0.84--1.32)   0.638
  0--20                 27/103/89     7/51/73     1.73(1.21--2.45)   0.002   37/103/79     12/57/61    1.48(1.07--2.05)   0.019    31/97/91     8/53/70     1.58(1.13--2.22)   0.008
  \>20                   15/63/55     17/90/93    1.20(0.85--1.69)   0.293    19/63/50     24/92/84    1.15(0.83--1.59)   0.414    15/60/58     19/88/93    1.10(0.79--1.54)   0.572

Variant homozygote/Heterozygote/Wild type homozygote;

Adjusted for age, exposure years, pack-years smoked, and occupation.

10.1371/journal.pone.0105226.t005

###### Function prediction of SNPs.

![](pone.0105226.t005){#pone-0105226-t005-5}

               regolumeDB   eQTL   Dnase   TFBS   H3K27ac     miRNA-LOSS
  ----------- ------------ ------ ------- ------ --------- ----------------
  rs1059829        1d        Y       Y      Y        Y      hsa-miR-541-5p
  rs1059279        3a        N       Y      Y        Y     
  rs1053411        4         N       N      N        Y       hsa-miR-4311

To deeply evaluate potential interactions of *SPARC* gene polymorphisms on the risk of CWP, we combined five polymorphisms based on the number of variant (risk) alleles (i.e.: rs1059279C, rs4958281T, rs2304052C, rsrs1059829T, rsrs1053411G). As shown in [Table 6](#pone-0105226-t006){ref-type="table"}, individuals with multiple risk alleles did have a higher risk of CWP (*P*trend = 0.015).

10.1371/journal.pone.0105226.t006

###### Frequency distributions of the combined genotypes between CWP cases and controls.
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             CWP cases   Controls   OR (95%CI)[a](#nt107){ref-type="table-fn"}     P     OR (95%CI)[b](#nt108){ref-type="table-fn"}     P                       
  --------- ----------- ---------- -------------------------------------------- ------- -------------------------------------------- ------- ------------------ -------
  2∼4           271       39.28                        288                       41.92                       1                                       1          
  5∼7           299       43.33                        323                       47.02                0.98(0.78--1.24)                0.888   0.99(0.79--1.25)   0.937
  8∼10          120       17.39                         76                       11.06                1.68(1.20--2.34)                0.002   1.68(1.20--2.34)   0.002
  P_trend                                                                                                                             0.016                      0.015

Variant homozygote/Heterozygote/Wild type homozygote;

Adjusted for age, exposure years, pack-years smoked, and occupation.

Discussion {#s4}
==========

SPARC, a matricellular protein secreted from several different cell types into the ECM, may modulate interactions between cells and the surrounding ECM [@pone.0105226-TrombettaEsilva1]. The elevated expression of SPARC has been reported in animal models of fibrotic disease and in human fibrotic tissues, including heart [@pone.0105226-Bradshaw2], lungs [@pone.0105226-Chang1], kidneys [@pone.0105226-Alpers1] and others. However, in patients with pulmonary fibrosis, the expression of SPARC was found to be increased and was localized to the cytoplasm of pulmonary fibroblasts [@pone.0105226-Kuhn1]. SPARC participates in collagen deposition probably through three mechanisms in the pathogenesis of pneumoconiosis. First, SPARC might bind procollagen and prevent its interaction with cellular receptors, such as the discoidin domain receptor (DDR) 2 and integrin α2β1 [@pone.0105226-TrombettaEsilva1]. In the absence of SPARC, procollagen accumulates at the cell surface, resulting in less total collagen and fewer thick collagen fibers. Second, there is a reciprocal regulatory mechanism between SPARC and TGF-β. Blocking of TGF-β signaling by the ALK-5 inhibitor SB-525334 significantly decreases SPARC expression as well as the degree of fibrosis in vivo [@pone.0105226-Shibata1], whereas decreased SPARC expression leads to decreased TGF-β activity [@pone.0105226-Zhou1]. Last, SPARC may activate nuclear localization of β-catenin and integrin-linked kinase (ILK) [@pone.0105226-Shi1]. The activation of β-catenin in fibroblasts promotes stabilization of the myofibroblast phenotype and an anti-apoptotic phenotype, while the activation of ILK leads to ROS production, one of the causative factors of recurrent epithelial damage in fibrotic lungs [@pone.0105226-Chang1], [@pone.0105226-Homma1].

Several mouse models have confirmed that SPARC is affiliated with pulmonary fibrosis. Savani et al. [@pone.0105226-Savani1] used bleomycin sulfate infused intra-tracheally at 0.15 U/mouse to cause a fibrotic response in WT and SPARC-null mice. The outcome revealed that SPARC-null mice had increased tissue destruction and increased inflammatory cell recruitment, specifically neutrophils, in comparison to bleomycin-treated WT mice. These findings were consistent with Sangaletti\'s study [@pone.0105226-Sangaletti1]. The reasons behind the outcome are not readily apparent, but SPARC could be produced by both bone marrow-derived and lung fibroblasts, and different sources might play a different role [@pone.0105226-Sangaletti2]. Sangaletti used bone marrow chimeric mice and found that expression of SPARC in pulmonary fibroblasts promoted collagen deposition, while the expression of SPARC in bone marrow cells impeded inflammatory infiltrates. This elaborate study demonstrated the intricate association between fibrosis and inflammation [@pone.0105226-Sangaletti2].

It is well known that genetic and environmental factors are involved in the development of CWP. To our knowledge, this is the first evaluation of the association between functional SNPs in *SPARC* and pneumoconiosis susceptibility in a Chinese population. Statistical analyses identified three SNPs (rs1059279, rs1059829, rs1053411) that were significantly associated with pneumoconiosis. In addition, the rs1059279 was not included in 1000 Genome database when we search for LD in SNP selection process. However, we found rs1059279 was in high linkage disequilibrium with rs1053411 (RSquared = 0.904) using our own genotyped data. Furthermore, stratification analyses were applied and hinted that each of these three SNPs (rs1059279, rs1059829, and rs1053411) significantly increased CWP risk of individuals with 0-20 pack-years smoking.

Furthermore, we speculate on the function of three SNPs: rs1053411 might affect the miRNA-LOSS of hsa-miR-4311, while rs1059829 might affect the miRNA-LOSS of hsa-miR-541-5p, which could well be involved in the regulation of mRNA production and stability. Moreover, rs1059829 was a locus of expression for Quantitative Trait Loci (eQTL) and Transcription Factor Binding Site (TFBS), thus could affect transcription activity and even consequently predispose individuals to excessive fibrogenesis. The relevant TFBS include Nfκb1, Interferon regulatory factor 4 (IRF4), B-cell CLL/lymphoma 3 (BCL3), and so on, all of which have innumerable links to the molecular mechanisms that result in the transcriptional activation of genes responsible for the fibrotic process. These findings set new insights into the role of SPARC in the pathogenesis of pneumoconiosis.

Several limitations of this study should be addressed. First, the possibility of selection bias of subjects could not be ruled out in this population-based, case-control study. Second, our sample size was only moderate, further studies are required to replicate our results in larger and more diverse ethnic populations. Third, since five SNPs were tested, one might apply an appropriate multiple testing correction, such as the Bonferroni correction, otherwise the significant association between these three SNPs and CWP risk should be interpreted with caution.

In conclusion, the present study indicates that three functional *SPARC* SNPs are associated with an increased risk of CWP in a Chinese population. Further functional research and validation studies with diverse populations are warranted to confirm our findings.
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